Brigit Biofarmaka Teknologi Tbk. vs Wismilak Inti Makmur Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Wismilak Inti Makmur Tbk. trades at Rp1,600 (market cap 3.4T, 1.57M 24h volume). The key difference: Wismilak Inti Makmur Tbk. is far larger — about 19.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Wismilak Inti Makmur Tbk. is more actively traded (1.57M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | WIIM | |
|---|---|---|
Market Cap | 172.82B | 3.4T |
Volume | 592.2K | 1.57M |
Lot | 5.92K | 15.75K |
Turnover | 147.05M | 2.54B |
Average Price | 248.31 | 1,610.77 |
Value | 147.05M | 2.54B |
Indicative Equilibrium Price | 254 | 1,600 |
Indicative Equilibrium Volume | 10 | 187 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Wismilak Inti Makmur Tbk (the Company) was established based on Notarial Deed No. 22 of Bagio Atmadja, S.H., dated December 14, 1994.
Read more on WIIM →